Interferon stimulating protein targeting compound, radiomarker thereof, and preparation method and application of interferon stimulating protein targeting compound and radiomarker

A compound and interferon technology, applied in the fields of radiopharmaceuticals and medical imaging, to achieve the effects of simple preparation method, short labeling time and strong labeling ability

Active Publication Date: 2021-06-08
XIAMEN UNIV
View PDF15 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Today's popular PD-1 / PD-L1 immune checkpoint inhibitors need to quantitatively screen the protein expression in patients in advance to achieve the purpose of precise treatment. Routine biopsy or immunohistochemistry (IHC) due to the heterogeneity of tumor tissue It is impossible to fully accurately and comprehensively evaluate the true expression of PD-1 / PD-L1

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Interferon stimulating protein targeting compound, radiomarker thereof, and preparation method and application of interferon stimulating protein targeting compound and radiomarker
  • Interferon stimulating protein targeting compound, radiomarker thereof, and preparation method and application of interferon stimulating protein targeting compound and radiomarker
  • Interferon stimulating protein targeting compound, radiomarker thereof, and preparation method and application of interferon stimulating protein targeting compound and radiomarker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Example 1. Dimeric amidobenzimidazole compound——DABI-PEG 2 -NH 2 (compound 12-1)

[0081] The synthetic route is as follows:

[0082]

[0083] Specifically include the following steps:

[0084] 1) Synthesis of compound 3

[0085] With 4-chloro-3 nitro-5 methoxybenzamide (compound 1) and (4-aminobut-2-en-1-yl) tert-butyl carbamate (compound 2) according to 1:1.2 molar ratio Dissolve in an appropriate amount of isopropanol, then add DIPEA in an equimolar ratio to compound 1 dropwise into the reaction bottle, stir and react overnight at room temperature, carry out aromatic nucleophilic substitution reaction, monitor the reaction process by TLC, spin the solvent after the reaction, and pass the crude product through Silica gel column was purified to obtain compound 3.

[0086] 2) Synthesis of Compound 4

[0087] 1) Dissolve the obtained compound 3 with an appropriate amount of methanol, transfer it to the reaction flask, and then slowly add 50 mL of hydrochloric ac...

Embodiment 2

[0098] Example 2. Dimeric amidobenzimidazole compound——DABI-Et 3 -NH 2 (compound 12-2)

[0099] The synthetic route is as follows:

[0100]

[0101] Specifically include the following steps:

[0102] 1) Synthesis of compound 3

[0103] Operation steps are the same as step 1) of embodiment 1.

[0104] 2) Synthesis of Compound 4

[0105] Operation steps are the same as step 2) of embodiment 1.

[0106] 3) Synthesis of compound 7-2

[0107] Weigh an equimolar amount of compound 5 (4-chloro-3 nitro-5 hydroxybenzamide) and compound 6-2 (6-(N-tert-butoxycarbonylamino)-1-hexanol, i.e. HO-Et 3 -NH-Boc) and triphenylphosphine (PPh 3 ) was dissolved in THF, and 2 times the molar amount of diisopropyl azodicarboxylate (DIAD) was added under ice-bath conditions to carry out a bimolecular nucleophilic substitution reaction, and reacted at room temperature for 24 hours. After the reaction was completed, the solvent was removed, and the crude product was passed through Compound 7...

Embodiment 3

[0117] Example 3. Interferon-stimulated protein-targeted radionuclide-labeled compound——[ 18 F]F-NOTA-PEG 2 -DABI

[0118] The synthetic route is as follows:

[0119]

[0120] Specifically include the following steps:

[0121] 1) NOTA-PEG 2 - Synthesis of DABI

[0122] Weigh the DABI-PEG prepared in Example 1 2 -NH 2 Dissolve in appropriate amount of DMF in equimolar ratio with NOTA-NHS, then add triethylamine, react for 48h, after reaction, add appropriate amount of hydrochloric acid to acidify and purify with high performance liquid chromatography (HPLC), mobile phase conditions: semi-preparative chromatographic column (250 ×10mm, 5μm, Thermo), phase A: water + 0.1% trifluoroacetic acid (TFA), phase B: acetonitrile + 0.1% TFA. Gradient elution conditions: 0-5min: 20%-28% B phase; 5-15min: 28% B phase; 15-20 min: 28%-39% B; 20-25min: 39%-95% B; 25 -40min: 20% phase B, flow rate: 3mL / min, UV wavelength: 254nm. The purified solution was dried in vacuo to obtain the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a dimeric amido benzimidazole compound. The structure of the dimeric amido benzimidazole compound is shown as a formula (I), wherein R0 is an integer of n from 0 to 5. The invention also provides a compound with anti-tumor activity and a radionuclide labeled compound targeted by interferon stimulating protein, wherein the compound is based on the dimeric amido benzimidazole compound. The dimeric amido benzimidazole compound has high affinity and high specificity to interferon stimulating protein, the compound with anti-tumor activity has the characteristic of activating an STING pathway in vitro, and the radionuclide labeled compound has the advantages that target uptake and non-target uptake are obviously compared, and the lipid solubility can be changed by introducing nuclides with different properties so that the application scene is greatly widened, and the compound can be combined with treatment nuclides for tumor treatment, and even can be used for immunotherapy.

Description

technical field [0001] The invention belongs to the technical field of radiopharmaceuticals and medical imaging, and in particular relates to a receptor molecular targeting compound and a preparation method thereof. Background technique [0002] Tumor is currently the primary killer threatening human health. In recent years, tumor immunotherapy has made outstanding achievements in improving the treatment of certain types of tumors, completely changing the status quo of tumor treatment, and has become another effective treatment for cancer following surgery, radiotherapy, chemotherapy, and targeted therapy. In 2018, the award of the Nobel Prize in Physiology and Medicine affirmed a completely new principle of cancer treatment by stimulating the innate ability of the body's immune system to attack tumor cells, and changed the treatment paradigm from immune enhancement to immune normalization. Tumor immunotherapy is mainly divided into two types: cellular immunotherapy and imm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/14A61K31/4184A61K51/04A61P35/00
CPCC07D403/14A61K51/0453A61P35/00Y02P20/55
Inventor 张现忠方建阳郭志德封丽霞
Owner XIAMEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap